Biocon's consolidated revenue from operations in Q2FY27 grew 2.2% to Rs 4,389 crore from Rs 4,296 crore, year-on-year (YoY).Biosimilars revenue increased 3% YoY to Rs 2,809 crore and Generics revenue grew 10% YoY Rs 774 crore.
Biocon's consolidated revenue from operations in Q2FY27 grew 2.2% to Rs 4,389 crore from Rs 4,296 crore, year-on-year (YoY).Biosimilars revenue increased 3% YoY to Rs 2,809 crore and Generics revenue grew 10% YoY Rs 774 crore.
<iframe src="https://hindustansphere.com/embed/cluster/9645b4c4d8f845096980df6210a296365e00bfdd" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Biocon Q2 Results: Net Profit Falls 51% To Rs 41 Crore, Revenue Rises 2% YoY; Misses Estimates"></iframe>
